[HTML][HTML] Threatment Strategies for Recurrent Hepatocellular Carcinoma Patients: Ablation and its Combination Patterns
J Bai, X Wang, Y Zhang, X Yan, X Xia, Y Feng… - Journal of …, 2024 - ncbi.nlm.nih.gov
With the development of guidance technology and ablation equipment, ablative procedures
have emerged as important loco-regional alternatives to surgical resection for recurrent …
have emerged as important loco-regional alternatives to surgical resection for recurrent …
A combination of sorafenib, an immune checkpoint inhibitor, TACE and stereotactic body radiation therapy versus sorafenib and TACE in advanced hepatocellular …
Z Zhang, C Li, W Liao, Y Huang, Z Wang - Cancers, 2022 - mdpi.com
Simple Summary Portal vein tumor thrombosis (PVTT) is the commonest type of
macrovascular invasion in hepatocellular carcinoma (HCC), while the effectiveness of …
macrovascular invasion in hepatocellular carcinoma (HCC), while the effectiveness of …
Interventional oncology of liver tumors: how it all started and where are we now: Interventional Oncology of liver tumors: How it all started and where are we now
LA Solbiati, Y Arai - The British Journal of Radiology, 2022 - academic.oup.com
Liver was the very first organ for which interventional procedures were applied for the local
treatment of primary and secondary malignancies. In this paper, the history of Interventional …
treatment of primary and secondary malignancies. In this paper, the history of Interventional …
Microwave ablation followed by cTACE in 5-cm HCC lesions: does a single-session approach affect liver function?
C Floridi, LM Cacioppa, N Rossini, M Macchini… - La radiologia …, 2024 - Springer
Purpose Microwave ablation (MWA) and conventional transarterial chemoembolization
(cTACE) are locoregional treatments commonly performed in very early, early and …
(cTACE) are locoregional treatments commonly performed in very early, early and …
Hepatocellular Carcinoma with Radiological Progression: Lenvatinib Plus PD-1 Inhibitor Combined with Microwave Ablation and Synchronous Transarterial …
Q Shi, P Huang, Z Zhang, W Zhang, L Liu… - Journal of …, 2023 - Taylor & Francis
Purpose To determine the clinical outcomes of lenvatinib plus PD-1 inhibitor combined with
microwave ablation (MWA) and synchronous transarterial chemoembolization (TACE) in …
microwave ablation (MWA) and synchronous transarterial chemoembolization (TACE) in …
[HTML][HTML] Liver transplantation following two conversions in a patient with huge hepatocellular carcinoma and portal vein invasion: A case report
LC Liang, WS Huang, ZX Guo, HJ You… - World Journal of …, 2024 - wjgnet.com
BACKGROUND Surgical resection and liver transplantation (LT) are the most effective
curative options for hepatocellular carcinoma (HCC). However, few patients with huge HCC …
curative options for hepatocellular carcinoma (HCC). However, few patients with huge HCC …
Longer Survival and Preserved Liver Function after Proton Beam Therapy for Patients with Unresectable Hepatocellular Carcinoma
T Nosaka, H Matsuda, R Sugata, Y Akazawa… - Current …, 2023 - mdpi.com
Background: Proton beam therapy (PBT) has been recently reported to achieve excellent
tumor control with minimal toxicity in patients with unresectable hepatocellular carcinoma …
tumor control with minimal toxicity in patients with unresectable hepatocellular carcinoma …
Transarterial chemoembolization for advanced hepatocellular carcinoma without macrovascular invasion or extrahepatic metastasis: analysis of factors prognostic of …
JH Kim, JH Kim, HK Yoon, GY Ko, JH Shin… - Frontiers in …, 2023 - frontiersin.org
Objectives To evaluate the safety and efficacy of TACE and factors predicting survival in
patients with advanced hepatocellular carcinoma (HCC) without macrovascular invasion …
patients with advanced hepatocellular carcinoma (HCC) without macrovascular invasion …
[HTML][HTML] Validation of the CRAFITY score for predicting prognosis in patients with hepatocellular carcinoma undergoing transarterial chemoembolization combined …
H Zhou, J Ren, F Wu, W Yang, D Zhu, Y Xie… - Journal of Interventional …, 2024 - Elsevier
Background The CRAFITY score can predict survival and radiological response to systemic
front-line treatment in patient with hepatocellular carcinoma (HCC). Aims In this study, we …
front-line treatment in patient with hepatocellular carcinoma (HCC). Aims In this study, we …
Y90 Radiation Segmentectomy versus Microwave Ablation for Hepatocellular Carcinoma in Locations Suboptimal for Percutaneous Ablation
O Kola, JA Cieslak, N Chauhan, P Gupta… - The Arab Journal of …, 2024 - thieme-connect.com
Purpose The purpose of our study was to evaluate outcomes following percutaneous
microwave ablation (MWA) versus yttrium-90 (Y90) radiation segmentectomy (RS) for tumors …
microwave ablation (MWA) versus yttrium-90 (Y90) radiation segmentectomy (RS) for tumors …